JBIO

Jade Biosciences, Inc. is a biotechnology company operating within the healthcare sector. With a market capitalization of $647.00 million and 30 employees, the company's scale is relatively modest. The company's financial health indicates significant losses, with a net income of -$93,958,000 over the trailing twelve months. Margins are not disclosed due to N/A values, but the debt-to-equity ratio stands at 0.48, suggesting moderate leverage. The current ratio of 5.81 suggests strong liquidity, with $198.90 million in cash and only $867,000 in debt. The company's valuation context is marked by an implied price-to-earnings (P/E) ratio that cannot be calculated due to N/A values. Growth rates are also not disclosed, making it difficult to assess the company's future prospects. The price-to-book ratio of 2.39 may provide some insight into the company's value relative to its book assets, but more information is needed to make a comprehensive assessment.